Closing the gender gap in human papillomavirus protection: A survey of healthcare workers
- 1Sengkang General Hospital, Singapore
Abstract
Infection with human papillomavirus (HPV) remains one of the most common sexually transmitted infections globally and is a leading cause of anogenital and oropharyngeal cancers.1 Although traditionally regarded as a women’s health issue because of its well-established association with cervical cancer and cervical screening programmes, HPV also contributes substantially to disease burden in men.2 Highly effective vaccines are available to prevent HPV infection and associated malignancies in both sexes.3 Many countries have therefore expanded vaccination programmes for HPV to include males.4 However, vaccine uptake among men remains suboptimal, and this disparity is often attributed to factors such as knowledge, perceived risk, cost, and healthcare provider recommendation.5,6
Related
- Closing the cardiovascular gender gap via AI: the EMABASK breast screening model, Basque Country
- Healthcare professionals' communication practices and preparedness in organised human papillomavirus-based cervical Cancer screening: A cross-sectional study in Central Portugal.
- Protecting workers from Algorithmic Management: a theoretical framework for four key protection factors
- Prevalence and factors associated with obesity among healthcare workers in Oman: a cross-sectional study
- Long COVID burden in healthcare workers: a 12-month survey of 771 cases
BibTeX
@article{chen2026closing,
title = {{Closing the gender gap in human papillomavirus protection: A survey of healthcare workers}},
author = {Jessica Weizhen Chen and Chaoyan Dong and Derrick Chen Wee Aw},
journal = {Annals, Academy of Medicine, Singapore},
year = {2026},
month = sep,
doi = {10.47102/annals-acadmedsg.2026419},
url = {https://doi.org/10.47102/annals-acadmedsg.2026419},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Closing the gender gap in human papillomavirus protection: A survey of healthcare workers
AU - Jessica Weizhen Chen
AU - Chaoyan Dong
AU - Derrick Chen Wee Aw
PY - 2026
DA - 2026/09/01
JO - Annals, Academy of Medicine, Singapore
DO - 10.47102/annals-acadmedsg.2026419
UR - https://doi.org/10.47102/annals-acadmedsg.2026419
AB - Infection with human papillomavirus (HPV) remains one of the most common sexually transmitted infections globally and is a leading cause of anogenital and oropharyngeal cancers.1 Although traditionally regarded as a women’s health issue because of its well-established association with cervical cancer and cervical screening programmes, HPV also contributes substantially to disease burden in men.2 Highly effective vaccines are available to prevent HPV infection and associated malignancies in both sexes.3 Many countries have therefore expanded vaccination programmes for HPV to include males.4 However, vaccine uptake among men remains suboptimal, and this disparity is often attributed to factors such as knowledge, perceived risk, cost, and healthcare provider recommendation.5,6
SN - 2972-4066
SN - 0304-4602
ER -